PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32279331-5	2020	In ETV6-ABL1 positive patients, a durable CHR was achieved by 4/9 patients (imatinib 1/5, nilotinib 2/3, dasatinib 1/1).	Dasatinib	105-114	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	8-12